David Allan Cairns
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 90
- Multiple Myeloma Research and Treatments 88
- Oncology 44
- Cancer Treatment and Pharmacology 21
- Peptidase Inhibition and Analysis 17
- Co-authors
- Rosamonde Elizabeth Banks (23 shared papers)Peter John Selby (22 shared papers)Christopher Robinson (1 shared paper)Gordon C Cook (40 shared papers)Douglas Thompson (12 shared papers)Anthea J. Stanley (10 shared papers)Mark Trehane Drayson (39 shared papers)Graham Jackson (40 shared papers)
- Journals
- Blood (32 papers)PROTEOMICS (7 papers)Leukemia (6 papers)British Journal of Haematology (6 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
David Allan Cairns
159 papers receiving 5.9k citations
David Allan Cairns's Hit Papers
Peers
Comparison fields: 5 of 121
- Hematology 3.0k
- Oncology 1.5k
- Genetics 510
- Molecular Biology 2.9k
- Cancer Research 471
Countries citing papers authored by David Allan Cairns
This map shows the geographic impact of David Allan Cairns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Allan Cairns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Allan Cairns more than expected).
Fields of papers citing papers by David Allan Cairns
This network shows the impact of papers produced by David Allan Cairns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Allan Cairns. The network helps show where David Allan Cairns may publish in the future.
Co-authors
The 25 scholars most cited alongside David Allan Cairns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma Hit paper breakdown → | 2015 | 480 |
| 2 | Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project Hit paper breakdown → | 2022 | 298 |
| 3 | 2018 | 290 | |
| 4 | 2015 | 269 | |
| 5 | 2016 | 223 | |
| 6 | 2005 | 205 | |
| 7 | 2004 | 204 | |
| 8 | 2017 | 202 | |
| 9 | 2009 | 153 | |
| 10 | 2021 | 130 | |
| 11 | 2014 | 127 | |
| 12 | 2016 | 119 | |
| 13 | Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease Hit paper breakdown → | 2023 | 109 |
| 14 | 2015 | 91 | |
| 15 | 2019 | 89 | |
| 16 | 2016 | 84 | |
| 17 | 2019 | 80 | |
| 18 | 2010 | 77 | |
| 19 | 2021 | 77 | |
| 20 | 2016 | 76 |
About David Allan Cairns
David Allan Cairns is a scholar working on Hematology, Oncology, Molecular Biology, Spectroscopy and Genetics, having authored 165 papers that have together received 6.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (88 papers), Protein Degradation and Inhibitors (35 papers), Cancer Treatment and Pharmacology (21 papers), Advanced Proteomics Techniques and Applications (18 papers), Peptidase Inhibition and Analysis (17 papers), Histone Deacetylase Inhibitors Research (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Hematology (3.0k citations), Oncology (1.5k citations), Genetics (510 citations), Molecular Biology (2.9k citations) and Cancer Research (471 citations). David Allan Cairns has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Rosamonde Elizabeth Banks, Peter John Selby, Christopher Robinson, Gordon C Cook, Douglas Thompson, Anthea J. Stanley, Mark Trehane Drayson, Graham Jackson, Jennifer H. Barrett and Gareth John Morgan. Their work appears in journals such as Blood, PROTEOMICS, Leukemia, British Journal of Haematology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.